279 related articles for article (PubMed ID: 29120809)
21. Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters.
Nikolić S; Keck CM; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):276-84. PubMed ID: 21600969
[TBL] [Abstract][Full Text] [Related]
22. Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method.
Hejri A; Khosravi A; Gharanjig K; Hejazi M
Food Chem; 2013 Nov; 141(1):117-23. PubMed ID: 23768336
[TBL] [Abstract][Full Text] [Related]
23. Pumpkin Oil-Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats.
Ahmed OAA; Fahmy UA; Bakhaidar R; El-Moselhy MA; Alfaleh MA; Ahmed AF; Hammad ASA; Aldawsari H; Alhakamy NA
Int J Nanomedicine; 2020; 15():2529-2539. PubMed ID: 32346290
[TBL] [Abstract][Full Text] [Related]
24. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
Negi LM; Jaggi M; Talegaonkar S
Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
[TBL] [Abstract][Full Text] [Related]
25. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
Kovačević AB; Müller RH; Keck CM
Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
[TBL] [Abstract][Full Text] [Related]
26. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
27. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
Lasoń E; Sikora E; Ogonowski J
Acta Biochim Pol; 2013; 60(4):773-7. PubMed ID: 24432330
[TBL] [Abstract][Full Text] [Related]
28. Rhamnolipids-based nanostructured lipid carriers: Effect of lipid phase on physicochemical properties and stability.
Azevedo MA; Cerqueira MA; Fuciños P; Silva BFB; Teixeira JA; Pastrana L
Food Chem; 2021 May; 344():128670. PubMed ID: 33272755
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone-3.
Lacerda SP; Cerize NN; Ré MI
Int J Cosmet Sci; 2011 Aug; 33(4):312-21. PubMed ID: 21284656
[TBL] [Abstract][Full Text] [Related]
30. Nanostructured lipid carriers loaded with free phytosterols for food applications.
Santos VDS; Braz BB; Silva AÁ; Cardoso LP; Ribeiro APB; Santana MHA
Food Chem; 2019 Nov; 298():125053. PubMed ID: 31260972
[TBL] [Abstract][Full Text] [Related]
31. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
32. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
Averina ES; Müller RH; Popov DV; Radnaeva LD
Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanocarriers containing Passiflora edulis seeds oil intended for skin application.
Krambeck K; Santos D; Otero-Espinar F; Sousa Lobo JM; Amaral MH
Colloids Surf B Biointerfaces; 2020 Sep; 193():111057. PubMed ID: 32388391
[TBL] [Abstract][Full Text] [Related]
34. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.
Attama AA; Schicke BC; Müller-Goymann CC
Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805
[TBL] [Abstract][Full Text] [Related]
35. Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design.
Varshosaz J; Eskandari S; Tabakhian M
Pharm Dev Technol; 2010; 15(1):89-96. PubMed ID: 19552542
[TBL] [Abstract][Full Text] [Related]
36. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
37. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
Salunkhe SS; Bhatia NM; Bhatia MS
Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
[TBL] [Abstract][Full Text] [Related]
38. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
40. Bemotrizinol-Loaded Carnauba Wax-Based Nanostructured Lipid Carriers for Sunscreen: Optimization, Characterization, and In vitro Evaluation.
Medeiros TS; Moreira LMCC; Oliveira TMT; Melo DF; Azevedo EP; Gadelha AEG; Fook MVL; Oshiro-Júnior JA; Damasceno BPGL
AAPS PharmSciTech; 2020 Oct; 21(8):288. PubMed ID: 33073311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
